Cargando…

Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma

INTRODUCTION: Plasma levels of eight combined proteins have shown value as biomarkers for detection of colorectal cancer (CRC). However, their value in identifying colorectal adenoma needs further evaluation. The aim was to evaluate the eight proteins (AFP, CA19-9, CEA, CyFra21-1, Ferritin, Galectin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Louise, Nielsen, Hans Jørgen, Christensen, Ib Jarle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434628/ https://www.ncbi.nlm.nih.gov/pubmed/32884322 http://dx.doi.org/10.2147/CEG.S251633

Ejemplares similares

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
por: Vizin, Tjasa, et al.
Publicado: (2012)

Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals
por: Thorsen, Stine Buch, et al.
Publicado: (2013)

Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients
por: Vižin, Tjaša, et al.
Publicado: (2014)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers
por: Rasmussen, Louise, et al.
Publicado: (2016)

Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
por: Jensen, Sarah Østrup, et al.
Publicado: (2019)

Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer
por: Post, Carolin, et al.
Publicado: (2002)

Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
por: Illemann, Martin, et al.
Publicado: (2014)

An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis
por: Dolin, Troels Gammeltoft, et al.
Publicado: (2021)

Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer
por: Thorsen, Stine F., et al.
Publicado: (2019)

Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer
por: Ørntoft, Mai‐Britt Worm, et al.
Publicado: (2020)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
por: Nielsen, Boye Schnack, et al.
Publicado: (2010)

Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

Data fusion in metabolomic cancer diagnostics
por: Bro, Rasmus, et al.
Publicado: (2012)

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer
por: Yuan, Zixu, et al.
Publicado: (2017)

Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer
por: Wang, Jing, et al.
Publicado: (2013)

Conserved serum protein biomarkers associated with growing early colorectal adenomas
por: Ivancic, Melanie M., et al.
Publicado: (2019)

Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients
por: Hetland, Merete Lund, et al.
Publicado: (2008)

Estimation of colorectal adenoma recurrence with dependent censoring
por: Hsu, Chiu-Hsieh, et al.
Publicado: (2009)

Metabolic factors accelerate colorectal adenoma recurrence
por: Taniguchi, Leo, et al.
Publicado: (2014)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Association of plasma C-reactive protein level with the prevalence of colorectal adenoma: the Colorectal Adenoma Study in Tokyo
por: Kigawa, Nano, et al.
Publicado: (2017)

Screening for colorectal cancer: possible improvements by risk assessment evaluation?
por: Nielsen, Hans J, et al.
Publicado: (2011)

Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers?
por: Wilhelmsen, Michael, et al.
Publicado: (2018)

Establishment and Verification of Scoring System for Colorectal Adenoma Recurrence
por: Xi, Xujie, et al.
Publicado: (2021)

Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
por: Smith, David Hersi, et al.
Publicado: (2014)

Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp
por: Hang, Dong, et al.
Publicado: (2019)

Risk factors for recurrence of colorectal conventional adenoma and serrated polyp
por: Chi, Zengjie, et al.
Publicado: (2021)

People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China
por: Ding, Hui, et al.
Publicado: (2016)

Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles
por: He, Chungang, et al.
Publicado: (2023)

Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas
por: Kang, Melissa, et al.
Publicado: (2013)

Targeted metabolomics analysis of nucleosides and the identification of biomarkers for colorectal adenomas and colorectal cancer
por: Zheng, Weifang, et al.
Publicado: (2023)

Colorectal Adenomas—Genetics and Searching for New Molecular Screening Biomarkers
por: Siskova, Anna, et al.
Publicado: (2020)

Identifying gene copy number variants associated with colorectal adenoma recurrence
por: Laukaitis, Christina M, et al.
Publicado: (2010)

Endoscopic and Histopathologic Predictors of Recurrence of Colorectal Adenoma on Lowering the Miss Rate
por: Ji, Jeong-Seon, et al.
Publicado: (2009)

Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence
por: Park, Jihye, et al.
Publicado: (2018)

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
por: Urup, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5t7tffc3qamm9oqd4u4i84spn4